MMIP Virtual Conference

The pandemic has highlighted the importance of global medicines supply chains, and generated unprecedented discussion around the manufacturing of medicines and vaccines; there has even been public discussion in the media about the challenges of manufacturing scale up and batch testing! In addition, against the backdrop of leaving the EU, the government has recognised the potential for enhanced manufacturing capability to contribute to economic growth and future resilience of the healthcare system. The Office for Life Sciences is developing an overarching strategy for UK medicines manufacturing, and this conference will focus on promoting the ongoing dialogue around how this strategy should be framed and then implemented – how the UK can play a more significant role in sustainable, efficient and resilient supply chains; the importance of developing a workforce for the future with the relevant skillsets; and the way we can harness technology and innovation to ensure the strategy plays into the government’s sustainability commitments.